Since there were no particular issues with the pre-admission tests, it was decided that I would undergo a prostate biopsy ...
Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026).
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), ...
LincolnshireWorld on MSN
Lincolnshire cancer patients benefit from faster radiotherapy treatment
Cancer patients in Lincolnshire can now benefit from a new radiotherapy treatment machine that can help save lives. The ...
November 2026 examEven after finishing your study for the Breast Cancer Specialist exam, you cannot determine through knowledge checks alone whether you can verbally explain your judgment when case ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...
Prostate cancer patients are benefitting from a machine that delivers radiotherapy treatment faster. The radiotherapy team at ...
As a screening test from Grail moves closer to Food and Drug Administration approval, cancer experts share what encourages ...
Dr. Roach weighs in on whether a patient should proceed with a prostate biopsy after conflicting test results.
A doctor advises a 68-year-old patient with a high 4Kscore result to proceed with a prostate biopsy despite a low-risk MRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results